# Marketaxess Holdings Inc: financial statements, quarterly

MKTX · Nasdaq · CIK 1278021 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mktx.md) · [Financials](/companies/mktx/financials.md) · [Filings](/companies/mktx/filings.md) · [Insiders](/companies/mktx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mktx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [172](/filings/0000950170-24-122345.md) | [197 d](/filings/0001193125-26-067009.md) | [210](/filings/0000950170-25-065612.md) | [198](/filings/0000950170-25-103993.md) | [207](/filings/0001193125-25-272335.md) | [202 d](/filings/0001193125-26-067009.md) | [209](/filings/0001193125-26-212081.md) | [219](/filings/0001193125-26-340249.md) | [209](/filings/0001193125-25-272335.md) | [209 d](/filings/0001193125-26-067009.md) | [233](/filings/0001193125-26-212081.md) | [218](/filings/0001193125-26-340249.md) |
| Operating income | $m | [66.9](/filings/0000950170-24-122345.md) | [77.0 d](/filings/0001193125-26-067009.md) | [92.5](/filings/0000950170-25-065612.md) | [81.3](/filings/0000950170-25-103993.md) | [87.1](/filings/0001193125-25-272335.md) | [80.0 d](/filings/0001193125-26-067009.md) | [88.4](/filings/0001193125-26-212081.md) | [91.9](/filings/0001193125-26-340249.md) | [85.6](/filings/0001193125-25-272335.md) | [76.0 d](/filings/0001193125-26-067009.md) | [101](/filings/0001193125-26-212081.md) | [89.9](/filings/0001193125-26-340249.md) |
| Interest expense | $m | [0.2](/filings/0000950170-23-055230.md) | [1.6 d](/filings/0000950170-24-018935.md) | [0.3](/filings/0000950170-24-054646.md) | [0.6](/filings/0000950170-24-091990.md) | [0.3](/filings/0001193125-25-272335.md) | [0.3 d](/filings/0001193125-26-067009.md) | [0.2](/filings/0001193125-26-212081.md) | [0.1](/filings/0001193125-26-340249.md) | [0.2](/filings/0001193125-25-272335.md) | [1.0 d](/filings/0001193125-26-067009.md) | [2.9](/filings/0001193125-26-212081.md) | [1.9](/filings/0001193125-26-340249.md) |
| Income tax | $m | [16.8](/filings/0000950170-24-122345.md) | [14.2 d](/filings/0001193125-26-067009.md) | [24.1](/filings/0000950170-25-065612.md) | [21.4](/filings/0000950170-25-103993.md) | [21.4](/filings/0001193125-25-272335.md) | [19.5 d](/filings/0001193125-26-067009.md) | [81.1](/filings/0001193125-26-212081.md) | [26.2](/filings/0001193125-26-340249.md) | [25.4](/filings/0001193125-25-272335.md) | [(12.6) d](/filings/0001193125-26-067009.md) | [25.8](/filings/0001193125-26-212081.md) | [21.4](/filings/0001193125-26-340249.md) |
| Net income | $m | [54.9](/filings/0000950170-24-122345.md) | [69.6 d](/filings/0001193125-26-067009.md) | [72.6](/filings/0001193125-25-272335.md) | [64.9](/filings/0001193125-25-272335.md) | [71.5](/filings/0001193125-25-272335.md) | [65.1 d](/filings/0001193125-26-067009.md) | [15.1](/filings/0001193125-26-340249.md) | [71.1](/filings/0001193125-26-340249.md) | [68.2](/filings/0001193125-25-272335.md) | [92.2 d](/filings/0001193125-26-067009.md) | [77.9](/filings/0001193125-26-340249.md) | [68.1](/filings/0001193125-26-340249.md) |
| Diluted EPS | $ per share | [1.46](/filings/0000950170-24-122345.md) | not reported | [1.92](/filings/0000950170-25-065612.md) | [1.72](/filings/0000950170-25-103993.md) | [1.90](/filings/0001193125-25-272335.md) | not reported | [0.40](/filings/0001193125-26-212081.md) | [1.91](/filings/0001193125-26-340249.md) | [1.84](/filings/0001193125-25-272335.md) | not reported | [2.20](/filings/0001193125-26-212081.md) | [1.93](/filings/0001193125-26-340249.md) |
| Basic EPS | $ per share | [1.47](/filings/0000950170-24-122345.md) | not reported | [1.92](/filings/0000950170-25-065612.md) | [1.72](/filings/0000950170-25-103993.md) | [1.90](/filings/0001193125-25-272335.md) | not reported | [0.40](/filings/0001193125-26-212081.md) | [1.91](/filings/0001193125-26-340249.md) | [1.84](/filings/0001193125-25-272335.md) | not reported | [2.21](/filings/0001193125-26-212081.md) | [1.93](/filings/0001193125-26-340249.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [420](/filings/0000950170-23-055230.md) | [451](/filings/0000950170-25-025606.md) | [377](/filings/0000950170-24-054646.md) | [434](/filings/0000950170-24-091990.md) | [446](/filings/0000950170-24-122345.md) | [544](/filings/0001193125-26-067009.md) | [486](/filings/0000950170-25-065612.md) | [463](/filings/0000950170-25-103993.md) | [473](/filings/0001193125-25-272335.md) | [520](/filings/0001193125-26-340249.md) | [377](/filings/0001193125-26-212081.md) | [246](/filings/0001193125-26-340249.md) |
| Total assets | $m | [1,738](/filings/0000950170-23-055230.md) | [2,015](/filings/0000950170-25-025606.md) | [1,927](/filings/0000950170-24-054646.md) | [1,887](/filings/0000950170-24-091990.md) | [1,833](/filings/0000950170-24-122345.md) | [1,789](/filings/0001193125-26-067009.md) | [1,878](/filings/0000950170-25-065612.md) | [1,975](/filings/0000950170-25-103993.md) | [2,014](/filings/0001193125-25-272335.md) | [1,935](/filings/0001193125-26-340249.md) | [2,302](/filings/0001193125-26-212081.md) | [2,422](/filings/0001193125-26-340249.md) |
| Total liabilities | $m | [547](/filings/0000950170-23-055230.md) | [722](/filings/0000950170-25-025606.md) | [609](/filings/0000950170-24-054646.md) | [557](/filings/0000950170-24-091990.md) | [447](/filings/0000950170-24-122345.md) | [401](/filings/0001193125-26-067009.md) | [531](/filings/0000950170-25-065612.md) | [574](/filings/0000950170-25-103993.md) | [624](/filings/0001193125-25-272335.md) | [777](/filings/0001193125-26-340249.md) | [1,098](/filings/0001193125-26-212081.md) | [1,169](/filings/0001193125-26-340249.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-067009.md) | not reported | not reported | not reported | [220](/filings/0001193125-26-340249.md) | [228](/filings/0001193125-26-212081.md) | [116](/filings/0001193125-26-340249.md) |
| Shareholders' equity | $m | [1,191](/filings/0000950170-24-122345.md) | [1,293](/filings/0001193125-26-067009.md) | [1,318](/filings/0001193125-25-272335.md) | [1,329](/filings/0001193125-25-272335.md) | [1,386](/filings/0001193125-25-272335.md) | [1,389](/filings/0001193125-26-340249.md) | [1,347](/filings/0001193125-26-340249.md) | [1,386](/filings/0001193125-26-340249.md) | [1,378](/filings/0001193125-25-272335.md) | [1,146](/filings/0001193125-26-340249.md) | [1,190](/filings/0001193125-26-340249.md) | [1,239](/filings/0001193125-26-340249.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [79.2 d](/filings/0000950170-24-122345.md) | [142 d](/filings/0001193125-26-067009.md) | [(4.9)](/filings/0000950170-25-065612.md) | [119 d](/filings/0000950170-25-103993.md) | [95.1 d](/filings/0001193125-25-272335.md) | [176 d](/filings/0001193125-26-067009.md) | [29.6](/filings/0001193125-26-212081.md) | [104 d](/filings/0001193125-26-340249.md) | [90.2 d](/filings/0001193125-25-272335.md) | [159 d](/filings/0001193125-26-067009.md) | [(75.3)](/filings/0001193125-26-212081.md) | [26.8 d](/filings/0001193125-26-340249.md) |
| Capital expenditure | $m | [6.0 d](/filings/0000950170-24-122345.md) | [2.1 d](/filings/0001193125-26-067009.md) | [1.2](/filings/0000950170-25-065612.md) | [7.7 d](/filings/0000950170-25-103993.md) | [0.8 d](/filings/0001193125-25-272335.md) | [0.2 d](/filings/0001193125-26-067009.md) | [1.9](/filings/0001193125-26-212081.md) | [1.2 d](/filings/0001193125-26-340249.md) | [1.5 d](/filings/0001193125-25-272335.md) | [3.6 d](/filings/0001193125-26-067009.md) | [0.3](/filings/0001193125-26-212081.md) | [0.6 d](/filings/0001193125-26-340249.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-122345.md) | [0.0 d](/filings/0001193125-26-067009.md) | [10.1](/filings/0000950170-25-065612.md) | [33.5 d](/filings/0000950170-25-103993.md) | [15.0 d](/filings/0001193125-25-272335.md) | [16.8 d](/filings/0001193125-26-067009.md) | [38.1](/filings/0001193125-26-212081.md) | [36.7 d](/filings/0001193125-26-340249.md) | [45.3 d](/filings/0001193125-25-272335.md) | [300 d](/filings/0001193125-26-067009.md) | [0.0](/filings/0001193125-26-212081.md) | [0.0 d](/filings/0001193125-26-340249.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.6](/filings/0000950170-23-055230.md) | [37.6](/filings/0000950170-24-054646.md) | [37.6](/filings/0000950170-24-091990.md) | [37.6](/filings/0000950170-24-122345.md) | [37.8](/filings/0000950170-25-065612.md) | [37.7](/filings/0000950170-25-103993.md) | [37.6](/filings/0001193125-25-272335.md) | [37.5](/filings/0001193125-26-212081.md) | [37.3](/filings/0001193125-26-340249.md) | [37.1](/filings/0001193125-25-272335.md) | [35.4](/filings/0001193125-26-212081.md) | [35.2](/filings/0001193125-26-340249.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,192,891 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340249.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.